Reported 687,068 shares, up 48,467 (7.6%) from the prior quarter.
Reported value -68.3%; share count 7.6% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2022-12-31 | 2538 |
| 2023-03-31 | 2322 |
| 2023-06-30 | 3543 |
| 2023-09-30 | 4152 |
| 2023-12-31 | 4702 |
| 2024-03-31 | 43552 |
| 2024-06-30 | 13810 |
| 2024-09-30 | 3759 |
| 2024-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2024 | Reduced | 0 | -737,168 (-100.0%) | 0 | $0 | 2025-02-14 | |
| Q3 2024 | Added | 737,168 | +50,100 (7.3%) | < 0.01% | $3,759 | 2024-11-12 | |
| Q2 2024 | Added | 687,068 | +48,467 (7.6%) | < 0.01% | $13,810 | 2024-08-07 | |
| Q1 2024 | Added | 638,601 | +438,511 (219.2%) | < 0.01% | $43,552 | 2024-05-03 | |
| Q4 2023 | Added | 200,090 | +142,090 (245.0%) | < 0.01% | $4,702 | 2024-02-08 | |
| Q3 2023 | Unchanged | 58,000 | 0 (0.0%) | < 0.01% | $4,152 | 2023-11-09 | |
| Q2 2023 | Unchanged | 58,000 | 0 (0.0%) | < 0.01% | $3,543 | 2023-08-07 | |
| Q1 2023 | Reduced | 58,000 | -905 (-1.5%) | < 0.01% | $2,322 | 2023-05-09 | |
| Q4 2022 | New | 58,905 | +58,905 (0.0%) | < 0.01% | $2,538 | 2023-02-09 |
Who else reported the position
39 managers reported CERO THERAPEUTICS HLDGS INC for Q2 2024.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Atalaya Capital Management LP | Reduced | 424,867 | -133 | 0.02% | $8,497,000 | 11 qtrs |
| Context Capital Management LLC | Unchanged | 122,013 | 0 | < 0.01% | $2,452,000 | 10 qtrs |
| Silver Rock Financial LP | Unchanged | 12,224 | 0 | < 0.01% | $246,000 | 7 qtrs |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | Added | 829,598 | +1,054 | < 0.01% | $16,592 | 11 qtrs |
| COWEN AND COMPANY LLC This report | Added | 687,068 | +48,467 | < 0.01% | $13,810 | 7 qtrs |
| CANTOR FITZGERALD L P | Unchanged | 441,048 | 0 | < 0.01% | $8,865 | 11 qtrs |
| Periscope Capital Inc | Reduced | 427,634 | -163,866 | < 0.01% | $8,595 | 10 qtrs |
| MMCAP International Inc SPC | Unchanged | 375,000 | 0 | < 0.01% | $7,538 | 11 qtrs |
| Saba Capital Management L P | Unchanged | 295,913 | 0 | < 0.01% | $5,948 | 11 qtrs |
| Linden Advisors LP | Unchanged | 249,999 | 0 | < 0.01% | $5,625 | 10 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2024
- Filed
- August 07, 2024
- Filing type
- 13F-HR
- Position type
- *W EXP 02/13/202
Voting authority reported
- Sole
- 687,068
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.